- Home
- GNS vs POM Comparison
GNS vs POM Comparison
Compare GNS & POM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GNS | POM |
|---|---|---|
| Founded | 2002 | 2015 |
| Country | Singapore | China |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Other Specialty Stores |
| Sector | Real Estate | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.0M | 47.2M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | GNS | POM |
|---|---|---|
| Price | $0.46 | $0.34 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 906.2K | 606.6K |
| Earning Date | 03-09-2026 | 05-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $156.26 | N/A |
| Revenue Next Year | $35.38 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.24 | $0.19 |
| 52 Week High | $1.92 | $6.43 |
Technical Indicators
Market Signals| Indicator | GNS | POM |
|---|---|---|
| Relative Strength Index (RSI) | 60.10 | 57.03 |
| Support Level | $0.36 | $0.21 |
| Resistance Level | $0.48 | $0.43 |
| Average True Range (ATR) | 0.04 | 0.04 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 88.53 | 90.71 |
Price Performance
Historical ComparisonAbout GNS Genius Group Limited
Genius Group Ltd is an Edtech and education company that provides entrepreneur education system business development tools and management consultancy services to entrepreneurs and entrepreneur resorts. Its revenue is derived from five reportable segments: Central, Academy, School, Resorts, and Discontinued operations. Geographically, it operates in Europe/Middle East/Africa, Asia/Pacific, and North America/South America.
About POM POMDOCTOR LIMITED American Depositary Shares
Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of revenue is derived from the Pharmaceutical supply chain segment.